Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Daily use of Colace (docusate sodium) for weeks or months is generally considered low risk because stool softeners are not stimulant laxatives and do not typically cause dependence, but most labels advise against use beyond one week without medical guidance. Ongoing need for a stool softener can signal an underlying issue such as low fiber or fluid intake, medication side effects (especially opioids), thyroid problems, pelvic floor dysfunction, or bowel obstruction, and warning signs like rectal bleeding, unexplained weight loss, severe pain, or no bowel movement for several days warrant prompt evaluation. There are several important factors that affect whether long term use is appropriate for you, including your age, other medications, and whether Colace is actually working, so see below to understand more.
Because constipation lasting months is a symptom rather than a diagnosis, it helps to clarify what is driving it before settling into an indefinite routine. A free, instant, online symptom check can help you sort out likely causes based on your specific pattern and flag anything that deserves a doctor's attention. It takes only a few minutes, requires no sign up, and gives you clear, personalized next steps so you can stop guessing and start addressing the root cause.
Last reviewed for medical accuracy: 09/13/2026
Is it safe to take Colace every day for months?
Colace (docusate sodium) is one of the most commonly used over-the-counter stool softeners. It helps ease constipation by drawing water into the stool, making bowel movements more comfortable. Many people wonder if it’s safe to use daily for an extended period. Below, we review what credible sources say about long-term Colace use, possible risks, and best practices for managing constipation.
Colace belongs to a class of medications called stool softeners. It:
Because it does not stimulate bowel muscles directly, Colace is generally gentler than stimulant laxatives (like senna or bisacodyl).
Using Colace briefly is well studied and considered safe. But what about months of daily use?
While Colace is generally well tolerated, using any laxative daily for months may carry risks:
Electrolyte imbalance
– Losing too much water through loose stools can alter sodium, potassium, and chloride levels.
– Symptoms: muscle cramps, weakness, irregular heartbeat.
Dependency mentality
– Although Colace is not habit-forming in the classic sense, users may grow anxious about skipping a dose.
– This can mask underlying bowel motility issues.
Gastrointestinal discomfort
– Some people report abdominal cramps, gas, or diarrhea with prolonged use.
– Persistent diarrhea can lead to dehydration.
Masking serious conditions
– Long-standing constipation sometimes signals thyroid problems, colon disease, or neurological disorders.
– Daily laxative use without evaluation may delay diagnosis.
If you’ve been taking Colace every day for more than two weeks, consider these red flags:
Before relying on any laxative long term, try incorporating these measures:
Fiber intake:
– Aim for 25–30 g per day from fruits, vegetables, whole grains.
– Consider a gradual increase to prevent gas.
Hydration:
– Drink at least 8 cups of water daily.
– Warm beverages (e.g., herbal tea) can stimulate gut motility.
Regular exercise:
– Even a 20-minute walk daily helps promote bowel movements.
Toileting habits:
– Establish a routine after meals (the gastrocolic reflex).
– Use a footstool to mimic a squatting position, easing stool passage.
Stress management:
– High stress can worsen gut function.
– Techniques like deep breathing or gentle yoga can help.
If you need ongoing support beyond 2–4 weeks:
Bulk-forming agents (psyllium, methylcellulose)
– Increase stool volume and improve consistency.
– Requires adequate fluid intake.
Osmotic laxatives (polyethylene glycol, lactulose)
– Draw water into the colon.
– Often used safely for months under medical supervision.
Prescription options
– For chronic idiopathic constipation or opioid-induced constipation, doctors may prescribe lubiprostone, linaclotide, or methylnaltrexone.
Always consult your healthcare provider if:
If you’re unsure about your symptoms, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker to get guidance on when to seek medical attention.
This information is based on guidelines from reputable medical organizations and the FDA’s prescribing information for docusate sodium. Always speak to a doctor about any persistent or severe health concerns.
(References)
* Hurdon V, Viola R, Schroder C. How useful is docusate in patients at risk for constipation? A systematic review of the evidence in the chronically ill. J Pain Symptom Manage. 2000 Feb;19(2):130-6. doi: 10.1016/s0885-3924(99)00157-8. PMID: 10699540.
* Frizelle F, Barclay M. Constipation in adults. BMJ Clin Evid. 2007 Aug 1;2007. Epub 2007 Aug 1. PMID: 19454117; PMCID: PMC2943807.
* Savary DL, Garon A. Son de blé et laxatifs: étude comparative chez des personnes âgées. Can Fam Physician. 1983 Sep;29:1627-30. PMID: 21283396; PMCID: PMC2153875.
* Mueller-Lissner SA, Wald A. Constipation in adults. BMJ Clin Evid. 2010 Jul 5;2010. Epub 2010 Jul 5. PMID: 21418672; PMCID: PMC3217654.
* 2014 Jun 26. PMID: 25520993.
* Mounsey A, Raleigh M, Wilson A. Management of Constipation in Older Adults. Am Fam Physician. 2015 Sep 15;92(6):500-4. PMID: 26371734.
* Chang L, Chey WD, Imdad A, Almario CV, Bharucha AE, Diem S, Greer KB, Hanson B, Harris LA, Ko C, Murad MH, Patel A, Shah ED, Lembo AJ, Sultan S. American Gastroenterological Association-American College of Gastroenterology Clinical Practice Guideline: Pharmacological Management of Chronic Idiopathic Constipation. Gastroenterology. 2023 Jun;164(7):1086-1106. doi: 10.1053/j.gastro.2023.03.214. PMID: 37211380; PMCID: PMC10542656.
* Date K, Williams B, Cohen J, Chaudhuri N, Bajwah S, Pearson M, Higginson I, Norrie J, Keerie C, Tuck S, Hall P, Currow D, Fallon M, Johnson M. Modified-release morphine or placebo for chronic breathlessness: the MABEL trial protocol. ERJ Open Res. 2023 Jul;9(4). doi: 10.1183/23120541.00167-2023. Epub 2023 Aug 14. PMID: 37583966; PMCID: PMC10423982.
* Zaman Z, Islam R, Koganti B, Falki V, Osentoski T, Graham S, Sharoar MG. Highly prevalent geriatric medications and their effect on β-amyloid fibril formation. BMC Neurol. 2024 Nov 14;24(1):445. doi: 10.1186/s12883-024-03930-7. Epub 2024 Nov 14. PMID: 39543530; PMCID: PMC11562802.
* Batool S, Chokkakula S, Kim BK, Park JH, Min SC, Lee JR, Lee GC, Lee DG, An SH, Jain A, Shin SC, Kim G, Jeon B, Baek YH, Song MS. High-throughput in vitro screening and in silico analysis for Zika virus inhibitor identification. Sci Rep. 2025 Nov 27;15(1):45501. doi: 10.1038/s41598-025-29585-z. Epub 2025 Nov 27. PMID: 41310171; PMCID: PMC12749539.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.